Prospective Observational Study Of Patients With Asymptomatic Centrally Located Advanced NSCLC Who Are Not Suitable For Curative Treatment
The aim of the study is to assess current practice within PROP & lung teams, for treating
asymptomatic patients with centrally located non-small cell lung cancer (NSCLC), and to
observe outcomes for those patients receiving immediate or deferred RT. This is a
prospective cohort trial. Patients will be managed by immediate radiation therapy (RT) or a
deferred approach according to physicians' individual current clinical practice. Baseline
and follow-up data collection will be structured to focus on patient-reported measures to
describe clinical outcomes in the two management groups. Indications for prescribing RT and
dose fractionation schedules will also be collected. A new intervention will not be
introduced during this trial. Instead, a follow-up regimen will be offered to both groups of
patients, so that RT can be offered to the deferred group of patients if/when symptoms
develop, and we can monitor symptoms/toxicities and QoL in both groups of patients.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society